Quantification of brain atrophy in patients with myotonic dystrophy and proximal myotonic myopathy: A controlled 3-dimensional magnetic resonance imaging study

Neuroscience Letters

Volumn 348, Issue 2, 2003, Pages 73-76

  Kassubek, Jan ^a   Juengling, Freimut D ^b   Hoffmann, Stefanie ^a   Rosenbohm, Angela ^a   Kurt, Anja ^a   Jurkat Rott, Karin ^a   Steinbach, Peter ^a   Wolf, Michael ^a   Ludolph, Albert C ^a   Lehmann Horn, Frank ^a   Lerche, Holger ^a   Weber, Yvonne G ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Brain atrophy; Brain imaging; Brain parenchymal fraction; Multisystemic disorder; Myopathy; Myotonia

Indexed keywords

CYTOSINE; GUANINE; THYMINE;

ADULT; AGED; ALLELE; ARTICLE; AUTOANALYSIS; BRAIN ATROPHY; BRAIN SIZE; BRAIN TISSUE; BRAIN TOMOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DNA DETERMINATION; EDUCATION; FEMALE; GENETIC ASSOCIATION; HUMAN; IN VIVO STUDY; MALE; MOTOR PERFORMANCE; MUSCLE ATROPHY; MYOTONIC DYSTROPHY; NUCLEOTIDE REPEAT; PARAMETER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS; THREE DIMENSIONAL IMAGING;

EID: 0042698355     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00740-7     Document Type: Article

References (19)

1. Ashburner J., Friston K. Multimodal image coregistration and partitioning - a unified framework. Neuroimage. 6:1997;209-217.
2. Avrahami E., Katz A., Bornstein N., Korczyn A.D. Computed tomographic findings of brain and skull in myotonic dystrophy. J. Neurol. Neurosurg. Psychiatry. 50:1987;435-438.
3. Chard D.T., Griffin C.M., Parker G.J., Kapoor R., Thompson A.J., Miller D.H. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain. 125:2002;327-337.
4. Di Costanzo A., Di Salle F., Santoro L., Bonavita V., Tedeschi G. T2 relaxometry of brain in myotonic dystrophy. Neuroradiology. 43:2001;198-204.
5. Fisher E., Rudick R.A., Simon J.H., Cutter G., Baier M., Lee J.C., Miller D., Weinstock-Guttman B., Mass M.K., Dougherty D.S., Simonian N.A. Eight-year follow-up study of brain atrophy in patients with MS. Neurology. 59:2002;1412-1420.
6. Harper P.S., Rüdel R. Myotonic dystrophy. Engel A.G., Franzini-Armstrong C. Myology. 2nd Edition: 1994; 1192-1219 McGraw-Hill Inc, NY, USA.
7. Huber S.J., Kissel J.T., Shuttleworth E.C., Chakeres D.W., Clapp L.E., Brogan M.A. Magnetic resonance imaging and clinical correlates of intellectual impairment in myotonic dystrophy. Arch. Neurol. 46:1989;536-540.
8. Hund E., Jansen O., Koch M.C., Ricker K., Fogel W., Niedermaier N., Otto M., Kuhn E., Meinck H.M. Proximal myotonic myopathy with MRI white matter abnormalities of the brain. Neurology. 48:1997;33-37.
9. Juengling F.D., Kassubek J. Standardized calculation of brain parenchymal fraction: an approach to objective assessment of cerebral atrophy. Am. J. Neuroradiol. 2003;. (in press).
10. Kassubek J., Tumani H., Ecker D., Kurt A., Ludolph A.C., Juengling F.D. Age-related brain parenchymal fraction is significantly decreased in young multiple sclerosis patients: a quantitative MRI study. NeuroReport. 14:2003;427-430.
11. Liquori C.L., Ricker K., Moseley M.L., Jacobsen J.F., Kress W., Naylor S.L., Day J.W., Ranum L.P.W. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science. 293:2001;864-867.
12. Mathieu J., De Braekeleer M., Prevost C., Boily C. Myotonic dystrophy: clinical assessment of muscular disability in an isolated population with presumed homogeneous mutation. Neurology. 42:1992;203-208.
13. Miaux Y., Chiras J., Eymard B., Lauriot-Prevost M.C., Radvanyi H., Martin-Duverneuil N., Delaporte C. Cranial MRI findings in myotonic dystrophy. Neuroradiology. 39:1997;166-170.
14. Moxley R.T., Meola G., Udd B., Ricker K. Report of 84th ENMC Workshop: PROMM (Proximal myotonic myopathy) and other myotonic dystrophy-like syndromes: 2nd workshop. Neuromuscul. Disord. 12:2002;306-317.
15. Naka H., Imon Y., Ohshita T., Honjo K., Kitamura T., Mimori Y., Nakamura S. Magnetization transfer measurements of cerebral white matter in patients with myotonic dystrophy. J. Neurol. Sci. 193:2002;111-116.
16. Ono S., Inoue K., Mannen T., Kanda F., Jinnai K., Takahashi K. Neuropathological changes of the brain in myotonic dystrophy - some new observations. J. Neurol. Sci. 81:1987;301-320.
17. Ranum L.P., Day J.W. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2. Curr. Neurol. Neurosci. Rep. 2:2002;465-470.
18. Rudick R.A., Fisher E., Lee J.C., Simon J., Jacobs L. Multiple Sclerosis Collaborative Research Group, Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Neurology. 53:1999;1698-1704.
19. Sansone V., Meola G., Cappa S.F., Cotelli M., Rognono F., Thornton C., Moxley R.T. 3rd. Magnetic resonance imaging and cognitive alterations in proximal myotonic myopathy. Neurology. 48:(Suppl.):1997;A230-A231.